IRWD vs BCRX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IRWD · Ironwood Pharmaceuticals$4.70 ▼ 0.21%
BCRX · BioCryst Pharmaceuticals$7.22 ▼ 1.37%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IRWD +41.6%
- BCRX +5.7%
Head to head
| Metric | IRWD | BCRX |
|---|---|---|
| Price | $4.70 | $7.22 |
| Change today | ▼ 0.21% | ▼ 1.37% |
| Market cap | $778.09M | $1.86B |
| Return, 3 months | +13.8% | -25.4% |
| Return, year to date | +39.5% | -7.4% |
| Return, 1 year | +48.7% | +3.6% |
| P/E (TTM) | 5.2 | – |
| P/B | -8.0 | -4.7 |
| P/E percentile vs own 5y | 55th | 70th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +9.0% | +13.1% |
| Net profit growth (YoY) | +49.3% | +193.9% |
| Gross margin | – | 97.9% |
| Operating margin | 62.8% | 42.5% |
| Net margin | 37.4% | -37.4% |
| Return on equity | – | – |
| Analyst target vs. price | +27.7% | +135.5% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 67 | 35 |
| 30-day volatility | 56.0% | 40.4% |
| Max drawdown, 1 year | -43.6% | -35.0% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BCRX is the largest of the group by market value.
- IRWD has returned the most over the past year.
- BCRX is growing revenue fastest.
- IRWD keeps the most profit per dollar of sales.
- BCRX has been the calmest stock over the last 30 days.